PDF(Pubmed)
Abstract：
BACKGROUND: Rectal cavernous hemangioma is a rare, benign vascular disease that seldom causes lower gastrointestinal bleeding, characterized by a high rate of misdiagnosis and missed diagnoses. Surgical treatment is considered to be relatively effective; however, it is accompanied by certain employed in the treatment of superficial hemangioma, boasting the advantages of minimally invasive surgery, including safety, effectiveness, reduced trauma, and rapid recovery. However, there is a lack of literature regarding the application of foam sclerosing agents for gastrointestinal hemangiomas.
UNASSIGNED: We present a case of a 60-year-old male who was admitted to our hospital with a history of recurrent hematochezia for >1 year and worsening symptoms for 1 week. The patient\'s medical history was unremarkable.
METHODS: Following colonoscopy, nuclear magnetic resonance imaging, computed tomography, and other examinations, the final diagnosis was rectal cavernous hemangioma.
METHODS: Due to the patient\'s refusal of surgery, endoscopic foam sclerotherapy using a lauromacrogol injection was performed after obtaining informed consent from the patient and their relatives.
RESULTS: Post-sclerotherapy, hematochezia symptoms ceased, and no adverse reactions were observed. Two months later, colonoscopy and nuclear magnetic resonance imaging showed that the hemangioma had almost completely disappeared, with only a small amount of tumor remnants, yielding a satisfactory curative effect.
CONCLUSIONS: Our findings indicate that endoscopic injection of a lauromacrogol foam sclerosing agent is a safe, effective, and minimally invasive treatment option for gastrointestinal cavernous hemangiomas.
UNASSIGNED: We present a case of a 60-year-old male who was admitted to our hospital with a history of recurrent hematochezia for >1 year and worsening symptoms for 1 week. The patient\'s medical history was unremarkable.
METHODS: Following colonoscopy, nuclear magnetic resonance imaging, computed tomography, and other examinations, the final diagnosis was rectal cavernous hemangioma.
METHODS: Due to the patient\'s refusal of surgery, endoscopic foam sclerotherapy using a lauromacrogol injection was performed after obtaining informed consent from the patient and their relatives.
RESULTS: Post-sclerotherapy, hematochezia symptoms ceased, and no adverse reactions were observed. Two months later, colonoscopy and nuclear magnetic resonance imaging showed that the hemangioma had almost completely disappeared, with only a small amount of tumor remnants, yielding a satisfactory curative effect.
CONCLUSIONS: Our findings indicate that endoscopic injection of a lauromacrogol foam sclerosing agent is a safe, effective, and minimally invasive treatment option for gastrointestinal cavernous hemangiomas.
摘要：
背景：直肠海绵状血管瘤是一种罕见的，很少引起下消化道出血的良性血管疾病，误诊率和漏诊率较高。手术治疗被认为是相对有效的;然而,它伴随着某些用于治疗浅表性血管瘤，拥有微创手术的优势，包括安全,有效性,减少创伤,和快速恢复。然而,缺乏有关泡沫硬化剂在胃肠道血管瘤中应用的文献。
■我们介绍一例60岁男性患者，住院>1年反复便血，症状恶化1周。患者的病史并不明显。
方法：结肠镜检查后，核磁共振成像，计算机断层扫描,和其他检查，最终诊断为直肠海绵状血管瘤。
方法：由于患者拒绝手术，在获得患者及其亲属的知情同意后,使用聚桂醇注射液进行内镜泡沫硬化治疗.
结果：硬化治疗后，便血症状停止，未观察到不良反应。两个月后,结肠镜和核磁共振成像显示血管瘤几乎完全消失，只有少量的肿瘤残留物，取得满意的疗效。
结论：我们的研究结果表明，内镜下注射聚桂醇泡沫硬化剂是一种安全的，有效,胃肠道海绵状血管瘤的微创治疗选择。
■我们介绍一例60岁男性患者，住院>1年反复便血，症状恶化1周。患者的病史并不明显。
方法：结肠镜检查后，核磁共振成像，计算机断层扫描,和其他检查，最终诊断为直肠海绵状血管瘤。
方法：由于患者拒绝手术，在获得患者及其亲属的知情同意后,使用聚桂醇注射液进行内镜泡沫硬化治疗.
结果：硬化治疗后，便血症状停止，未观察到不良反应。两个月后,结肠镜和核磁共振成像显示血管瘤几乎完全消失，只有少量的肿瘤残留物，取得满意的疗效。
结论：我们的研究结果表明，内镜下注射聚桂醇泡沫硬化剂是一种安全的，有效,胃肠道海绵状血管瘤的微创治疗选择。
